Medical Device News Magazine

Babson Diagnostics Welcomes New Clinical Advisor, Dr Andrew Carroll

Healthtech company adds key clinical expertise as it moves closer to commercialization of its next-generation blood testing ecosystem

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Babson Diagnostics, a science-first health care technology company, today announced the addition of a clinical advisor who will bring valuable insights of the medical community in the ongoing development and introduction of the company’s new diagnostic blood testing service, BetterWay™. Andrew Carroll, M.D., a family physician and clinical assistant professor at the University of Arizona College of Medicine, will provide advice and counsel about clinical best practices and review validation data and reports.

Dr Andrew Carroll is a leading voice in family medicine, having served on the board of directors of the American Academy of Family Physicians, a professional organization representing more than 130,000 doctors. He also has extensive experience in the areas of new healthcare delivery models, healthcare information technology, and medical informatics.

“Dr. Carroll joins the Babson team as a highly recognized leader in the industry and brings first-hand clinical experience as we move closer to launch,” said David Stein, Babson’s chief executive officer. “His deep understanding of what is critical to physicians and their patients will bring value and clinical guidance to fulfilling Babson’s mission of making blood testing easier and patient-centered.”

Babson’s BetterWay blood testing reimagines diagnostic testing – from collection to sample preparation to analysis. Requiring only a pea-sized capillary sample from a finger, BetterWay is designed to eliminate the need for collection of large tubes of blood for analysis while maintaining medically accurate results clinicians and their patients can trust.

Dr. Carroll will join Babson at industry events, trade shows, and clinical meetings. He will also assist in assembling a clinical advisory board to support the company in embedding clinical best practices.

Dr. Carroll is the founder, owner and medical director at Atembis LLC in Chandler, Arizona, where he is focused on providing cost-conscientious care for patients who are not eligible for federal or state insurance benefits.

“Effective care starts with having the best health information about your patients and much of that critical data comes from blood testing,” Dr. Carroll said. “I love collaborating with innovative companies like Babson who are focused on making health easier for all.”

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”